Stoelting's Anesthesia and Co-Existing Disease · 8th Edition
Valvular Heart Disease
Thank you for studying with us
The website closes on August 31st and the chapter audio moves to YouTube, free. Everything here is unlocked until then.
If you've supported us already — thank you, genuinely. If this helped you and you'd like to put something toward the last of the running costs, it means a lot.
0:00 / 0:00
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Key Takeaways
- Stenotic valve lesions produce pressure overload and concentric hypertrophy, while regurgitant lesions cause volume overload with eccentric hypertrophy and chamber dilation.
- Aortic stenosis presents with exertional dyspnea, angina, and syncope; once symptomatic, intervention via surgical or transcatheter valve replacement becomes imperative.
- Mitral stenosis, caused primarily by rheumatic heart disease, requires strict heart rate control perioperatively to preserve adequate diastolic filling time.
- Aortic regurgitation generates widened pulse pressure and depends on compensatory tachycardia and vasodilation to reduce regurgitant volume and maintain forward flow.
- Mechanical prosthetic valves offer superior durability but carry higher thrombotic risk, while bioprosthetic valves have limited lifespan but lower thromboembolism risk.
- Doppler echocardiography provides both diagnostic confirmation and ongoing surveillance for all valvular pathology and guides management decisions.
Chapter SummaryWhat this audio overview covers
Valvular heart disease encompasses structural abnormalities of the heart's four valves that result in either stenotic obstruction or regurgitant backward flow, each triggering distinct compensatory mechanisms and clinical presentations. Stenotic lesions create fixed obstructions that generate upstream pressure overload and concentric ventricular hypertrophy, while regurgitant lesions permit retrograde blood flow causing volume overload and eccentric hypertrophy with chamber dilation. Aortic stenosis, predominantly arising from degenerative calcification or bicuspid anatomy, produces the classic triad of exertional dyspnea, angina, and syncope as the left ventricle compensates through concentric remodeling; definitive management via surgical or transcatheter valve replacement becomes necessary once symptoms emerge due to dramatically elevated mortality risk. Aortic regurgitation, whether chronic from structural valve disease or acute from endocarditis and dissection, generates a widened pulse pressure and necessitates modest tachycardia and vasodilation to minimize regurgitant volume and optimize forward flow. Mitral stenosis, almost exclusively caused by rheumatic heart disease, restricts left ventricular filling and elevates atrial pressures, potentially progressing to pulmonary hypertension and atrial fibrillation; perioperative management prioritizes strict heart rate control to preserve diastolic filling time. Mitral regurgitation, arising from acute papillary muscle dysfunction or chronic degenerative processes, reduces forward cardiac output through systolic backflow into the left atrium and benefits from afterload reduction strategies. Right-sided valve pathology, including tricuspid and pulmonic disorders, frequently occurs as secondary phenomena from pulmonary hypertension and right ventricular dysfunction rather than primary valve abnormality. Prosthetic valve selection involves weighing the superior durability but thrombogenicity of mechanical valves against the limited lifespan but lower thrombotic risk of bioprosthetic options. Doppler echocardiography remains the diagnostic and surveillance cornerstone for all valvular lesions, while infective endocarditis prophylaxis is now reserved for highest-risk patients including those with prosthetic valves or prior infection undergoing procedures with significant bacteremia risk.